Slideshow

sTMS Device May Prevent Migraine

A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.

Related Videos
Anna Pace, MD
Klaus Werner, MD & Alon Ironi
MaryAnn Mays, MD
© 2024 MJH Life Sciences

All rights reserved.